Robot-assisted surgery for moderate brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Bleeding is in the basal ganglia area and confirmed by a CT scan
- The amount of blood in the brain is 15 to 30 mL (not including exactly 30 mL)
- You have symptoms like trouble speaking, arm or leg weakness (strength 3 or less), or a high stroke severity score
- The bleeding is stable, meaning it hasn't increased much over at least 6 hours
- Your level of consciousness is good (GCS score 9 or higher)
- Surgery can be done within 72 hours from when the bleeding started
- You had little to no disability before this bleeding (mRS score 0 or 1)
- You don't have conditions that would make surgery unsafe, like a bleeding disorder or use of blood thinners within the past week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
This trial tests a new, less invasive surgery using a robot to help guide the doctor to drain blood from a brainstem bleed. It may be an option for people who can have surgery soon after the bleed and who have a certain level of consciousness.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Hear when a new Basal Ganglia Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.